|
Mar 12
|
ACHV: 2Q:25 NDA Submission
|
|
Mar 12
|
Q4 2024 Achieve Life Sciences Inc Earnings Call
|
|
Mar 12
|
Achieve Life Sciences Inc (ACHV) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...
|
|
Mar 11
|
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2024 and Provides Update on the Cytisinicline Development Program
|
|
Feb 18
|
Here are Rogue Funds Updates on Achieve Life Sciences (ACHV)
|
|
Feb 11
|
Achieve Life Sciences to Present at the Oppenheimer Healthcare Life Sciences Conference
|
|
Feb 10
|
Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial
|
|
Jan 2
|
Should You Expect a Strong Re-rating for Achieve Life Sciences (ACHV) Post Results in Q1?
|
|
Nov 11
|
ACHV: Commercialization in Focus
|
|
Oct 16
|
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline
|
|
Oct 10
|
Achieve Life Sciences Announces Completion of Enrollment in ORCA-OL Clinical Trial & Successful Outcome of the First Data Safety Monitoring Committee Meeting
|
|
Oct 1
|
Achieve Life Sciences Strengthens Leadership with Appointment of Dr. Mark Rubinstein, Nicotine Dependence Expert, as New Head of Medical Affairs
|
|
Jul 31
|
Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence
|
|
Jul 29
|
Achieve Life Sciences Announces $20M Loan Refinancing with Silicon Valley Bank
|
|
Jul 25
|
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024
|
|
May 13
|
ACHV: First Quarter Results
|
|
May 10
|
Achieve Life Sciences Inc (ACHV) Reports Q1 2024 Financial Results
|
|
May 10
|
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Q1 2024 Earnings Call Transcript
|
|
May 9
|
Achieve Life Sciences Reports Financial Results for First Quarter 2024 and Provides Corporate Update
|
|
May 6
|
Achieve Life Sciences Announces Publication of Cytisinicline Vaping Cessation Trial Results in JAMA Internal Medicine
|